SNB's Tschudin (post-policy statement) says Swiss GDP growth was exceptionally strong in the second quarter, with unusually robust performance in the chemicals/pharmaceuticals industry
SNB's Tschudin reported exceptionally strong Q2 Swiss GDP driven by pharmaceuticals, but forecasts moderate upcoming growth supported by monetary policy, franc depreciation, and foreign demand amid global risks.
News detail
Capacity utilisation was below average, especially in manufacturing, while unemployment rose again somewhat through to early summer. Expect moderate growth for the coming quarters. Growth stimuli are likely to continue emanating from abroad. Moreover, our monetary policy and the recent depreciation of the Swiss franc are having a supportive effect. The main risk to the economic outlook for Switzerland stems from developments in the global economy. In particular, the situation in the Middle East and the trade policy environment.
What do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
